Citation: Fernando-Miguel Gamboa-Antiñolo. The essential measures to improve the management of anaphylaxis[J]. AIMS Medical Science, 2020, 7(4): 293-297. doi: 10.3934/medsci.2020018
[1] |
Golden DBK (2017) Anaphylaxis: recognizing risk and targeting treatment. J Allergy Clin Immunol Pract 5: 1224-1226. doi: 10.1016/j.jaip.2017.06.028
![]() |
[2] | Sienra-Monge JL, Navarrete-Rodriguez EM, Chavez-Flores U, et al. (2019) Anaphylaxis in children and adults: prevention, diagnosis and treatment. Rev Conamed 24: 107-164. [Article in Spanish]. |
[3] |
Alvarez-Perea A, Ameiro B, Morales C, et al. (2017) Anaphylaxis in the pediatric emergency department: analysis of 133 cases after an allergy workup. J Allergy Clin Immunol Pract 5: 1256-1263. doi: 10.1016/j.jaip.2017.02.011
![]() |
[4] |
Wood RA, Camargo CA, Lieberman P, et al. (2014) Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Imunol 133: 461-467. doi: 10.1016/j.jaci.2013.08.016
![]() |
[5] |
Ma L, Danoff TM, Borish L (2014) Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 133: 1075-1083. doi: 10.1016/j.jaci.2013.10.029
![]() |
[6] |
Turner PJ, Jerschow E, Umasunthar T, et al. (2017) Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract 5: 1169-1178. doi: 10.1016/j.jaip.2017.06.031
![]() |
[7] |
Greenberger P, Rotskoff BD, Lifschvitz B (2007) Fatal anaphylaxis: post-mortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 98: 252-257. doi: 10.1016/S1081-1206(10)60714-4
![]() |
[8] | Pumphrey RS (2004) Fatal anaphylaxis in the UK: 1992–2001. Novartis Found Symp 257: 116-128. |
[9] |
Yunginger JW, Nelson DR, Squillace DL, et al. (1991) Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 36: 857-865. doi: 10.1520/JFS13095J
![]() |
[10] |
Pumphrey RS (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30: 1144-1150. doi: 10.1046/j.1365-2222.2000.00864.x
![]() |
[11] |
Campbell RL, Li JTC, Nicklas RA, et al. (2014) Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol 113: 599-608. doi: 10.1016/j.anai.2014.10.007
![]() |
[12] |
Bonds RS, Asawa A, Ghazi AI (2015) Misuse of medical devices: a persistent problem in self-management of asthma and allergic disease. Ann Allergy Asthma Immunol 114: 74-76. doi: 10.1016/j.anai.2014.10.016
![]() |
[13] |
Ridolo E, Montagni M, Bonzano L, et al. (2015) How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients. Intern Emerg Med 10: 937-941. doi: 10.1007/s11739-015-1255-z
![]() |
[14] |
Ewan P, Braithwaite N, Leech S, et al. (2016) BSACI guideline: prescribing an adrenaline auto-injector. Clin Exp Allergy 46: 1258-1280. doi: 10.1111/cea.12788
![]() |
[15] |
Mehr S, Robinson M, Tang M (2007) Doctor—How do I use my EpiPen? Pediatr Allergy Immunol 18: 448-452. doi: 10.1111/j.1399-3038.2007.00529.x
![]() |
[16] |
Saleh-Vandenberg J, deVries S, Bak E, et al. (2017) Incomplete and incorrect epinephrine auto-injector training to food allergic patients by pharmacists in the Netherlands. Pediatr Allergy Immunol 28: 238-244. doi: 10.1111/pai.12688
![]() |
[17] |
Salter SM, Loh R, Sanfilippo F, et al. (2014) Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement. Allergy Asthma Clin Immunol 10: 49. doi: 10.1186/1710-1492-10-49
![]() |
[18] |
Mahoney B, Walklet E, Bradley E, et al. (2019) Improving adrenaline autoinjector adherence: a psychologically informed training for healthcare professionals. Immun Inflamm Dis 7: 214-228. doi: 10.1002/iid3.264
![]() |
[19] |
Antiñolo FMG (2015) How incorrect is the use of adrenaline auto-injectors? Intern Emerg Med 10: 887-888. doi: 10.1007/s11739-015-1290-9
![]() |
[20] |
Waserman S, Avilla E, Ben-Shoshan M, et al. (2017) Epinephrine autoinjectors: new data, new problems. J Allergy Clin Immunol Pract 5: 1180-1191. doi: 10.1016/j.jaip.2017.06.027
![]() |
[21] | Brown AFT (2009) Current management of anaphylaxis. Emergencias 21: 213-223. |
[22] |
García-Magán C, Montero JMG, Moure-González JD, et al. (2020) Rapid and safe use of adrenaline auto-injectors: We have a problem!. An Pediatr (Barc) 92: 388-389. [Article in Spanish]. doi: 10.1016/j.anpedi.2019.11.006
![]() |